133 related articles for article (PubMed ID: 2905254)
41. A comparison of roxatidine acetate and ranitidine in duodenal ulcer healing.
Hüttemann W
Drugs; 1988; 35 Suppl 3():90-5. PubMed ID: 2905255
[TBL] [Abstract][Full Text] [Related]
42. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
Ichikawa T; Ishihara K; Saigenji K; Hotta K
Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
[TBL] [Abstract][Full Text] [Related]
43. Comparative effects of H2-receptor antagonists on drug interaction in rats.
Lin JH; Cocchetto DM; Yeh KC; Duggan DE
Drug Metab Dispos; 1986; 14(6):649-53. PubMed ID: 2877821
[TBL] [Abstract][Full Text] [Related]
44. Roxatidine, an H(2) receptor blocker, is an estrogenic compound--experimental evidence.
Agrawal SS; Alvin Jose M
Syst Biol Reprod Med; 2010 Aug; 56(4):286-91. PubMed ID: 20718616
[TBL] [Abstract][Full Text] [Related]
45. Effect of a new H2-receptor antagonist (roxatidine acetate) on the acid secretion by isolated canine parietal cells.
Saito E; Natomi H; Kato M; Sugano K; Seki A; Takaku F; Yasumura R; Matsuo Y
Gastroenterol Jpn; 1989 Apr; 24(2):221. PubMed ID: 2568303
[No Abstract] [Full Text] [Related]
46. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
47. Roxatidine suppresses inflammatory responses via inhibition of NF-κB and p38 MAPK activation in LPS-induced RAW 264.7 macrophages.
Cho EJ; An HJ; Shin JS; Choi HE; Ko J; Cho YW; Kim HM; Choi JH; Lee KT
J Cell Biochem; 2011 Dec; 112(12):3648-59. PubMed ID: 21809375
[TBL] [Abstract][Full Text] [Related]
48. Effects of HOE 760 (histamine H2-receptor antagonist) on diazepam pharmacokinetics.
Meyer BH; Müller FO; Badian M; Hundt HK; Joubert AL; Luus HG
S Afr Med J; 1988 Apr; 73(7):421-3. PubMed ID: 2895963
[TBL] [Abstract][Full Text] [Related]
49. [Clinical evaluation of roxatidine acetate hydrochlorides as a preanesthetic medication].
Namba M; Chihara E; Ibuki T; Ashida H; Fukushima H; Tanaka Y
Masui; 2001 Feb; 50(2):127-35. PubMed ID: 11244765
[TBL] [Abstract][Full Text] [Related]
50. H2-antagonists and alcohol. Do they interact?
Gugler R
Drug Saf; 1994 Apr; 10(4):271-80. PubMed ID: 7912509
[TBL] [Abstract][Full Text] [Related]
51. Roles of extracellular Ca++ and calmodulin in roxatidine-stimulated secretion and synthesis of mucus by cultured rabbit gastric mucosal cells.
Takahashi S; Okabe S
J Pharmacol Exp Ther; 1998 Jan; 284(1):37-42. PubMed ID: 9435158
[TBL] [Abstract][Full Text] [Related]
52. Pharmacokinetic and pharmacodynamic properties of histamine H2-receptor antagonists. Relationship between intrinsic potency and effective plasma concentrations.
Lin JH
Clin Pharmacokinet; 1991 Mar; 20(3):218-36. PubMed ID: 1673880
[TBL] [Abstract][Full Text] [Related]
53. A comparison of roxatidine acetate and ranitidine in gastric ulcer healing.
Judmaier G
Drugs; 1988; 35 Suppl 3():120-6. PubMed ID: 2905240
[TBL] [Abstract][Full Text] [Related]
54. Roxatidine acetate in the long term maintenance of gastric ulcers.
Börsch G
Drugs; 1988; 35 Suppl 3():134-8. PubMed ID: 2905242
[TBL] [Abstract][Full Text] [Related]
55. A comparison of roxatidine acetate 150 mg once daily and 75 mg twice daily in duodenal ulcer healing.
Hentschel E; Schütze K
Drugs; 1988; 35 Suppl 3():96-101. PubMed ID: 2905256
[TBL] [Abstract][Full Text] [Related]
56. Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.
Kubitza D; Becka M; Zuehlsdorf M; Mueck W
J Clin Pharmacol; 2006 May; 46(5):549-58. PubMed ID: 16638738
[TBL] [Abstract][Full Text] [Related]
57. Effects of changing the type of H2-blocker in the treatment of H2-blocker-resistant ulcers: comparison of roxatidine acetate hydrochloride and other H2-blockers.
Yasutake K; Amano M; Mizokami Y; Kubota S; Fukumoto H; Imamura Y; Yokoya H; Irie K
J Int Med Res; 1998; 26(1):25-36. PubMed ID: 9513074
[TBL] [Abstract][Full Text] [Related]
58. Effects of combined use of roxatidine and pirenzepine on gastric secretion in humans.
Misawa T; Chijiiwa Y; Yoshida K; Tanaka A; Kabemura T; Fujishima H; Harada N; Nawata H
Fukuoka Igaku Zasshi; 1990 Jul; 81(7):242-6. PubMed ID: 1976580
[TBL] [Abstract][Full Text] [Related]
59. The influence of H2 receptor antagonists on the plasma concentrations of midazolam and temazepam.
Elliott P; Dundee JW; Elwood RJ; Collier PS
Eur J Anaesthesiol; 1984 Sep; 1(3):245-51. PubMed ID: 6152615
[TBL] [Abstract][Full Text] [Related]
60. Effect of antacid and H2 receptor antagonists on the intestinal absorption of folic acid.
Russell RM; Golner BB; Krasinski SD; Sadowski JA; Suter PM; Braun CL
J Lab Clin Med; 1988 Oct; 112(4):458-63. PubMed ID: 2902178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
